Rennova Health Shares Appeal Win in Eleventh Circuit Court of Appeals

- September 25th, 2017

Rennova Health received a favorable decision from the Eleventh Circuit Court of Appeals reversing an earlier decision by the US District Court.

Rennova Health (NASDAQ:RNVA) received a favorable decision from the Eleventh Circuit Court of Appeals reversing an earlier decision by the US District Court.
As quoted in the press release:

Biohealth Medical Laboratory, Inc. and PB Laboratories, LLC (the “Companies”) filed suit against CIGNA Health in 2015 alleging that CIGNA failed to pay claims for laboratory services the Companies provided to patients pursuant to CIGNA-issued and CIGNA-administrated plans. In 2016, the U.S. District Court dismissed part of the Companies’ claims for lack of standing. The Companies appealed that decision to the Eleventh Circuit Court of Appeals, which recently reversed the district court’s decision and found that the Companies have standing to raise claims arising out of traditional insurance plans as well as self-funded plans.
“This is an exciting development for us,” said Seamus Lagan, Chief Executive Officer, “and allows us to push forward in our pursuit of the total amount of our original claims.”

Click here to read the full press release.

Source: www.marketwired.com

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply